• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Catalog Number VS-402
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 07/26/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician used venaseal to treat the a 23cm segment of the great saphenous vein(gsv) on (b)(6) 2018.The procedure was completed without issue.The catheter tip was 5cm caudal to the sapheno femoral junction (sfj) prior to delivery of adhesive and compression was used.It was reported the vein did close.The patient presented on (b)(6) 2018 with a raised red, firm know around the insertion site.The physician treated the patient with 2 rounds of medrol dose packs.Initially, an improvement was noted but then new areas developed on both treated legs.The original areas healed.The physician then administered 40mg prednisone for 2 weeks.The physician reported that the patient didn¿t have any drainage and that a course of antibiotics was used without any change.The physician does not know of any history with the patient that would now have led him to believe that there would be a reaction to the venaseal procedure.The patient had no history of ulcerative colitis.During follow-up with the patient, it was discovered that the patient started taking methotrexate in july for heel cracking.In the physician¿s experience and in research found, this medication¿s main side effect would be boils and skin sores.Patient has stopped the medication and is continuing the dose of prednisone prescribed for another week.The patient is scheduled for further follow up visit.
 
Manufacturer Narrative
Patient is doing much better.The sores are healing and no new ones have formed.The physician feels that the methotrexate was the issue.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8063317
MDR Text Key126905773
Report Number9612164-2018-03157
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberVS-402
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/26/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-